Brand Boost Guidelines

Feb 9, 2024
Download
Latest in Home
X Ray Radiography Tech Patient 400
Bone-RADS improves accuracy for junior, attending physicans
October 17, 2025
Crohn Disease Sign Adobe Dizain
MRI, CT, ultrasound biomarkers help identify Crohn disease strictures
October 17, 2025
United States Map 400
Low breast cancer screening prevalence tied to socioeconomic factors
October 17, 2025
2025 10 16 Chemo Brain Thumbnail
PET/CT reveals ‘chemo brain’ regions in leukemia patients
October 16, 2025
Related Stories
Images obtained in a 50-year-old female patient with a new biopsy-proven malignant lesion in the left breast. (A) Craniocaudal mammogram of the right breast does not show any lesion. (B) The malignant lesion corresponds with a 7-cm irregular and spiculated mass on the left craniocaudal mammogram. Ultrasound-guided core-needle biopsy revealed grade 2 invasive lobular carcinoma. (C) The bilateral positron emission mammographic craniocaudal color image obtained one hour after intravenous injection of 185 MBq of F-18-labeled fluorodeoxyglucose (F-18 FDG) shows a mass with intense uptake in the left breast with known cancer and no abnormal uptake in the right breast. Positron emission mammographic craniocaudal images of the left breast obtained (D) one hour and (E) four hours after intravenous injection of 185 MBq of F-18 FDG show no substantial visual difference in uptake of the known cancer. (F) Axial contrast-enhanced fat-saturated subtracted T1-weighted MR image with maximum intensity projection reconstruction obtained 90 seconds after intravenous injection of 0.1 mmol of gadolinium-based contrast material per kilogram of body weight also shows the enhancing mass corresponding to known malignancy (arrow) and marked bilateral background parenchymal enhancement, with multiple nonspecific foci of enhancement in the contralateral breast. The patient opted for bilateral mastectomy, which confirmed left-sided malignancy and no malignancy in the contralateral breast. Image courtesy of the RSNA,
Womens Imaging
Low-dose PEM shows promise in breast cancer detection
Ambulance
Interventional
EVT valuable in patients requiring transit to stroke centers
Data analysis validation. Panel A: Image and line profile through the bottle on scans 1 (top) and 2 (middle), and the difference image (bottom) calculated according to Equation 3. Panel B: Data from a representative participant showing the effect of the dose correction on the PETWALK image using Equation 1 when applied to co-registered images in native subject space. The images were then warped to standard Montreal Neurological Institute (MNI) space Top: PETSTAND, middle – uncorrected PETWALK, bottom – corrected PETWALK. The color bar shows image intensity across the three images. Image courtesy of NeuroImage.
Molecular Imaging
PET reveals brain’s energy demands during walking
Artificial Intelligence Lung Color (1)
CT
AI boosts CTPA's ability to predict lung disease survival
More in Home
Bone-RADS improves accuracy for junior, attending physicans
By Amerigo Allegretto
ACR's Bone-RADS led to improved diagnostic accuracy for junior and attending physicians, but lower accuracy for senior physicians.
October 17, 2025
X Ray Radiography Tech Patient 400
MRI, CT, ultrasound biomarkers help identify Crohn disease strictures
By Kate Madden Yee
The findings of a review published in Radiographics could help clinicians determine the best treatment for the disease.
October 17, 2025
Crohn Disease Sign Adobe Dizain
Low breast cancer screening prevalence tied to socioeconomic factors
By Amerigo Allegretto
Geographic trends show that low cancer screening participation is linked to socioeconomic disadvantages.
October 17, 2025
United States Map 400
PET/CT reveals ‘chemo brain’ regions in leukemia patients
By Will Morton
Chemotherapy is associated with brain metabolic alterations, particularly in areas governing cognition and emotion.
October 16, 2025
2025 10 16 Chemo Brain Thumbnail
Stanford AIDE lab proposes radiology AI safety monitoring model
By Liz Carey
EMM was developed to monitor FDA-cleared radiological AI devices as a complement to retrospective monitoring.
October 16, 2025
David Larson Md Stanford Aide Lab 2025
Low-field MRI improves Alzheimer's research access
By Kate Madden Yee
Why? Because the technology could be more geographically accessible, researchers noted.
October 16, 2025
Alzheimers Amyloid
Could more imaging access improve prison cancer care?
By Amerigo Allegretto
One potential strategy for improving cancer care among incarcerated individuals is more access to screening tests.
October 15, 2025
Doctors Working Monitor Consult 400
PI-RADS v2.1 is 'highly sensitive' for prostate cancer detection on MRI
By Kate Madden Yee
PI-RADS v2.1 was developed by the ACR and the European Society of Urogenital Radiology (ESUR) and released in 2019.
October 15, 2025
Prostate Cancer 3 D Rendering
qHDMI differentiates radial scars from invasive breast cancer
By Amerigo Allegretto
Angiogenesis-based biomarkers from ultrasound can differentiate between radial scar lesions and invasive breast cancer.
October 15, 2025
2025 10 14 Breast Qhdmi Ultrasound Thumbnail
Lung biopsy before surgery linked to cancer recurrence
By Will Morton
The findings confirm concerns about “tumor cell spillage” during the procedure.
October 14, 2025
2025 10 14 Tumor Seeding Thumbnail
Abnormal CT-FFR results translate to up to 7 years of cardiovascular risk
By Kate Madden Yee
The prognostic value of CT fractional flow reserve (CT-FFR) has been unclear, but a recent study's findings offer further insight.
October 14, 2025
Heart Damage
PSMA-PET/CT reporting varies widely in the U.S.
By Will Morton
Standardized interpretation frameworks for PSMA-PET/CT reporting are underused in the U.S.
October 14, 2025
2025 10 14 Incidental Findings Psma Pet Ct Thumbnail
Page 1 of 178
Next Page